To test if this TGFβ production by tumor cells may be responsible for Treg accumulation in BLM-treated mice, we sorted CD4+ GFP+ from Foxp3-EGFP mice and stimulated them with T cell receptor (TCR) triggering. This evidence concerns the gene CD4 and Bloom syndrome.